Navigation Links
Frommer Lawrence & Haug's Thomas J. Kowalski Named to the International Who's Who of Patent Attorneys
Date:4/28/2010

CHICAGO, April 28 /PRNewswire/ -- Frommer Lawrence & Haug partner and BIO 2010 presenter, Thomas J. Kowalski, has been named to the International Who's Who of Patent Attorneys for 2010-11.  This is Mr. Kowalski's first nomination to the prestigious list, which features the world's leading practitioners in patent law.

Only patent attorneys who have received multiple independent nominations from clients and fellow attorneys are included in the listing, published by Who's Who Legal.  Official copies of the publication, which will feature Mr. Kowalski's national and international biotechnology expertise, will be issued in mid-May.

Mr. Kowalski brings his breadth of experience to BIO 2010.  He will be joined by FLH partners, Brian Malkin, Bob McWright and Grace Pan; associate Dr. Deborah Lu; and Scientific Advisor Dr. Smitha Uthaman at exhibit booth 2734, where the FLH delegation will feature a number of articles on biotechnology authored by members of the Firm and answer questions of fellow participants and exhibitors.

On May 6, Mr. Kowalski will join Dr. Maria Fotaki, Biotechnology Director of the European Patent Office and several others and present at the BIO 2010 session, "Effective Academia and Industry Interactions: The Role of Patents in Attracting Industry Interest in this Economy."  The session will be held from 8:00am to 9:30am in room N427A at McCormick Place and will shed light on the ways in which industry and academia might effectively partner to drive research programs, especially in this age of economic uncertainty.

"It is a very great honor to be nominated to this list of the world's top patent attorneys based on my biotech patent work, and I am most grateful to all who considered me worthy of this honor," Mr. Kowalski said.  "BIO 2010 is an excellent venue to engage in a robust dialogue on the most current issues facing the vibrant biotech industry.  All of us at FLH believe in being value added, and look forward to providing a worthwhile contribution to the discussion," he added.

About FLH

Founded in 1997, Frommer Lawrence & Haug LLP has quickly proven its expertise in intellectual property, transactional, regulatory, and antitrust law.  The firm is dedicated to developing creative, multidisciplinary solutions to legal issues and business problems in diverse practice areas.  At FLH, the first concern is that its legal strategies make business sense.  Its attorneys act as skilled architects of legal solutions that result in significant commercial success.


'/>"/>
SOURCE Frommer Lawrence & Haug LLP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
2. Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons
3. DOE to Explore Scientific Cloud Computing at Argonne, Lawrence Berkeley National Laboratories
4. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
5. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
6. SACHEM Launches New Products for High Purity Advanced Ceramic Powders : Avanta AC™ Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles
7. Polymathic Analytical Labs Debuts at World's Largest Medical Design & Manufacturing Exhibition
8. M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks
9. Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
10. Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel
11. Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... March 01, 2017 , ... ... will demonstrate how concentrating on protection, productivity and quality can help food and ... range of solutions – from x-ray and checkweighing to vision inspection and metal ...
(Date:3/1/2017)... 2017  Elizabeth Young and Joshua Rosenthal , ... Washington University,s Health Workforce Speaker series. http://bit.ly/2lA6C8B ... will be speaking on March 9, 2017 at the ... Washington, DC at 12:00pm. The ... renowned speakers to examine new workforce configurations, their outcomes ...
(Date:2/28/2017)... Diego, California (PRWEB) , ... ... ... Inc., the supplier of 3D nano-porous silicon biosensors and instruments for sensitive, ... and St. Marianna University, School of Medicine in Japan. The collaborators expect ...
(Date:2/28/2017)... , Feb. 28, 2017  Phosphorus, a ... today the formation of the Phosphorus Scientific Advisory ... experts chosen to advise the company on the ... multi-site research initiatives. Please visit http://phosphorus.com/about-us/ ... initiatives. "We,ve gathered some of the ...
Breaking Biology Technology:
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
Breaking Biology News(10 mins):